Objectives. To evaluate the clinical efficacy, cost and acceptability of a shared care system of patient-or general practitioner (GP)-initiated hospital review in rheumatoid arthritis (RA).
Rheumatoid arthritis (RA) is a chronic but variable be seen when they do not require help but do not have easy, rapid access to support at times of need. disease requiring continuing specialist and multidiscipli- Faulkner and Frankel [3] suggested a variety of ways nary care [1] , often including lifetime routine reviews of optimizing out-patient services (e.g. increasing disby hospital rheumatologists. Patterns of hospital review charge rates, lengthening the interval between routine vary but most patients attend every 3 months initially, follow-up visits), but when implemented locally these extending to 6-12 months as the course of the disease had minimal impact on an unwieldy system. becomes established. Planned follow-up review of RA Furthermore, they do not address the fundamental belief patients forms up to 75% of the average rheumatologist's underpinning the traditional system-that RA patients workload [2] . Consequently, out-patient clinics are heavrequire regular hospital-initiated review throughout their ily booked in advance and, as the system becomes lifelong illness. difficult to manipulate, both routine new patient waiting General practitioners (GPs) do not wish to manage time and the wait for urgent review during disease their RA patients alone and lose the expertise of the exacerbations are unacceptably long, causing dissatisfacrheumatologist and specialist multidisciplinary team, but tion for patient, GP and rheumatology staff. In addition, the traditional system is not optimal [4] . A more flexible at routine reviews the patient's disease is often quiet system of review might reduce inappropriate follow-up and little or no intervention is required-patients may appointments, improve rapid access to specialist advice and release resources to further improve service provision. If the patient is empowered to initiate specialist review, then feelings of enhanced self-efficacy and or necessity, lengthen the interval between routine follow-up visits such that patients are infrequently (usually not the study rheumatologist), who decided on the timing of the review. In the rare event of an reviewed. There is little hard evidence about whether it is clinically safe to reduce routine specialist input; thereemergency (e.g. septic arthritis), all patients would be dealt with immediately. Control patients had access to fore, this study includes a 'safety net' to monitor the clinical progress of patients receiving both traditional, the occupational therapist (OT ) and physiotherapist (PT ) via the traditional route of GP request, rheumatoplanned reviews and no routine reviews but rapid access (shared care).
logist appointment and referral to OT or PT waiting lists. At medical, OT or PT hospital reviews, all patients Controlled studies of shared care in other diseases have been performed [5] , but most did not incorporate were managed according to need and further follow-up was given as clinically indicated, SCG patients eventually patient-initiated access to hospital review. Studies in RA have concentrated on monitoring for adverse effects of returning to patient-initiated review and controls to routine review. slow-acting anti-rheumatic drugs (SAARDs) [6 ] . Mowat et al. [7] randomized 72 RA patients to GP, consultant or specialist occupational therapist follow-up and found Outcome measures that all three systems were equally effective, but they did not use patient-initiated review.
Clinical and psychological This study used a randomized controlled trial to
To assess the overall state of RA, evaluations of plasma compare traditional, routine rheumatologist-initiated viscosity, C-reactive protein, haemoglobin, hand X-rays hospital care for patients with established RA with a
[11], grip strength, range of movement at the knee and patient-initiated shared care system in which there were elbow, and articular index [12] were made at 0 and 24 no routine hospital reviews, but hospital review was months. Clinical and psychological status was measured initiated by patients and GPs. The hypotheses addressed at 3-month intervals with a questionnaire that covered are that the patient-initiated shared care system will pain and disease activity [10-cm visual analogue scale show an improvement in clinical and psychological ( VAS )], disability (Health Assessment Questionnaire) outcome, a reduction in the overall use of healthcare [13, 14] , days lost from work, helplessness (Arthritis resources, and greater satisfaction with care by patients Helplessness Index) [15] , anxiety and depression and GPs.
(Hospital Anxiety and Depression Scale) [16 ] , selfefficacy [17] and changes in medication.
Method
Satisfaction Three hundred and two consecutive patients attending Satisfaction with and confidence in the system of care the rheumatology out-patients department of the Bristol were recorded using a 10 cm VAS every 3 months. At Royal Infirmary and who had established RA according 24 months, GPs were asked the same question and GPs to international criteria [8] were invited to take part, of SCG patients were also asked whether they wished the study having received approval from the United their patients to continue in the shared care system. Bristol Health Care Trust Research Ethics Committee. All RA patients were invited, with no exclusion criteria.
Resources After receiving information on both arms of the study, Visits to health professionals about arthritis (including patients who gave consent were randomized to either the use of hospital transport) were recorded in patients' shared care with the GP [no routine hospital review but diary cards. The costs of all hospital visits were calcurapid access on request; the shared care group (SCG)] lated using local NHS Trust figures while GP, district or traditional hospital care [regular planned review; the and practice nurse visits and hospital transport journeys control group] for 2 yr. SCG patients were cared for were costed using published unit cost data [18] . by their GPs, who were provided with management guidelines based on previous publications [9, 10] .
Safety net monitoring [Responsibility for monitoring SAARDs is held routinely by GPs in this locality.]
A safety net, using the 3-monthly questionnaires (assessed blind), was set up to monitor all patients' Access to rheumatologist, occupational therapist or clinical status as half were no longer receiving reviews. physiotherapist review Based on clinical experience, an increase of Á20% in pain, disease activity or disability was deemed a safety SCG patients or GPs requested review by any team member through the nurse-run telephone helpline, net failure. Shared care patients who failed the safety net were telephoned to check on their well-being and whereby general advice or assistance was also given. Fortnightly ring-fenced rheumatology clinics gave a encouraged to see their GP, while those who failed on two consecutive occasions were encouraged to come for maximum wait of 10 working days for review. Control patients had a traditional medical review ordered rourheumatologist review. Hospital records of control patients who failed were checked to ensure they were tinely every 3-4 months or according to standard practice. Requests for medical review of control patients not lost to follow-up. Case notes were reviewed at 24 months by an independent assessor, who documented ahead of schedule were dealt with according to normal practice, GP requests being assessed by a rheumatologist RA complications using a predetermined checklist.
Sample size and statistics
In order to show a 12% change in pain using a 10 cm VAS, at 95% power, the study required a sample size of 186 patients [19] . Analysis was performed on all those who completed four or more of the nine data sets. Changes in parameters between the two groups of patients at intermediate time points and over 2 yr were compared using Student's t-test or the Mann-Whitney U-test (non-parametric data).
Results
Of 302 subjects invited to participate, 209 (69.2%) agreed. Patients who declined were older, had a higher mean articular index and were more disabled ( Table 1) .
No patient declined to take part after randomization, although the GP of one SCG patient declined on grounds of comorbidity (but did enter other patients).
Of the 208 entered, 26 (12.5%) withdrew or were withdrawn because of non-compliance with safety monitoring (SCG, 11; control group, 15); nine patients died (SCG, 5; control group, 4) but their data are included where available (n = 182; SCG, 93; control group, 89) ( Fig. 1) . At entry patients showed moderate inflammatory activity, pain and disability and appeared representative of a hospital-based RA population ( Table 1) . There were no significant differences between the two groups, other than for grip strength (P < 0.05). Clinical and psychological benefit P < 0.05; 24 months, P < 0.053) (Fig. 4) . Although again there were trends in favour of the shared care The majority of the 3-monthly questionnaires were group for changes in psychological status over 24 returned (SCG, 88.8%; control group, 88.9%). There months (anxiety and depression increased by 3 and 4%, was a significant difference between the groups for pain respectively, in SCG and by 11 and 14% in the control at 24 months (SCG, 3.9 cm, control group 4.8 cm; group), there were no significant differences between the P < 0.05) (Fig. 2) , and change in pain over months groups for changes in psychological status. 0-24 was significantly less in shared care patients (SCG,
The frequency of safety-net failures was not signifi-+0.4; control group, +1.6 cm; P < 0.01). There was a cantly different between the groups (SCG, 26.5%; contrend in favour of the SCG patients for changes in trol group, 28.9%), although more control patients failed patient opinion of disease activity over 24 months (SCG, the safety net on a second review 3 months after failing -8%; control group, +17%; not significant). Mean a first review ( Table 2 ). Of the shared care patients who disability fluctuated very little over the 2 yr (SCG failed, the majority had already sought advice or did improved by 8%, control group deteriorated by 4%) and not require it. there were no statistically significant differences for
The proportions of patients treated with non-steroidal change in mean disability over 24 months ( Fig. 3) .
anti-inflammatory drugs (NSAIDs), SAARDs and There were significant differences in self-efficacy for function at 6, 15, 18 and 21 months (SCG stronger, all glucocorticoids were equal in the groups at entry and control group (no significant difference).
Resource use
Shared care appointments were given within a mean of remained relatively constant throughout the 2 yr ( Table 3 ). Assuming that NSAIDs might have been 4.9 working days (range 0-18 days). In the eight cases where the delay was >10 working days, this coincided changed at either a GP or a hospital consultant visit, there was one NSAID prescription change for every with staff or bank holidays and a consequent clinic postponement. There was a 43.8% difference in consultnine SCG doctor visits (i.e. an alteration ratio of 1:9, vs 1:18 for the control group) and, assuming only rheumant reviews [SCG requested 262 appointments, with a mean of 2.82; controls were given 466 reviews, with a atologists were likely to alter SAARDs, a SAARD alteration ratio of 1:6 SCG consultant reviews (control mean of 5.24; P < 0.001), but no significant differences in visits to other professionals ( Table 4) . The overall group, 1:10).
At the 24-month case note review, four instances of cost for managing the 93 SCG patients was £38 635 (£208 per patient per year) vs £55 597 for the 89 control RA complications were documented for SCG patients (one instance each of respiratory and gastrointestinal patients (£313 per patient per year). This represents a saving for the SCG of 30.5% overall, or, when the complications and two instances of nodules) while controls had 10 instances (three instances of vasculitis, three difference in group sizes are taken into account, 33.5% (P < 0.001). The helpline received a mean of 2.4 calls of drug reactions, two of gastrointestinal complications, one each of renal and nodules). At entry, Larsen scores per week, which in most units would be managed by existing nurse specialists. significantly higher in the SCG when patients were asked to look back over the 2 yr (SCG, 8.56 cm; controls, To test the robustness of these costings, a sensitivity analysis was undertaken, using various values for the 7.89 cm; P < 0.05). Confidence in the system to care for them was significantly higher in SCG, in six of the eight two main contributing factors: hospital consultant visits and GP visits ( Fig. 5 ). Even at unrealistically low cross-sectional assessments (Fig. 6) . At 24 months, 82 SCG patients were invited to continue with shared care costings for hospital consultant visits (£50) and inappropriately high costings for GP consultations (£55), i.e. a (five died, four had other comorbidities, one was discharged, one was non-compliant with safety questionsituation in which consultations in primary care are more expensive than consultations in secondary care, naires, and one was diagnosed with systemic lupus erythematosus) and all accepted. At 24 months there the overall cost saving for the study was 14%.
was no significant difference between the groups for GP Satisfaction satisfaction and confidence (satisfaction: SCG, 7.66 cm; controls, 7.39 cm; confidence: SCG, 7.46 cm; controls, Satisfaction and confidence levels were high for both systems and not significantly different at entry (satisfac-7.65 cm). Of the 70% of SCG GPs who answered the F. 5. Sensitivity analysis of various costings for consultant and GP visits.
F. 6. Confidence in the system: comparison of mean scores with 95% confidence interval.
question, 80% wished their patients to continue in the care patients, although this was not statistically significant. However, although extra GP visits were inherent shared care system, 8% preferred them to revert to traditional care and 12% expressed no preference.
in the study design, no GP declined to participate and most wished patients to continue at the end. Consultant availability had to be protected during Discussion this research study as it was not known how many patients would request appointments, nor how freThis randomized controlled trial compared a patientinitiated system of shared care including open access to quently. The reported 33.5% saving does not take account of the ring-fenced shared care appointments the hospital specialist team with the traditional system of routine consultant review in RA. Results suggest no that were not utilized by patients, leaving some consultant appointments unused. Clearly the saving is only clinical deterioration and some clinical benefit in the shared care group, which was achieved at a 33.5% achieved if fewer staff are employed or more patients cared for. However, the data now allow us to estimate resource saving and incorporated greater satisfaction and confidence in the system. that, by utilizing the unfilled consultant appointment slots, approximately 50% more patients could be accomThe groups were similar in all respects at entry, and it is therefore unlikely that differences in disease status modated in this shared care system without extra medical input. If the system were to be scaled up to incorporate could have influenced overall findings. Patients who declined to take part were significantly older and more the majority of a consultant's RA patients (perhaps 8-fold ), then more than one rapid access clinic would affected by their arthritis. It may be that the decliners were anxious about making a major change in a wellbe required each fortnight, which would increase the number of clinics available to patients. The study implies established care system or were uncertain about initiating consultant review themselves, although no data are that involving patients in their management reduces the overall need for medical consultations (GP plus hospital available on this. Shared care might need to be targeted at certain patient groups. consultant visits) without increasing either physiotherapy or occupational therapy input, although there was The increased ratio of prescription changes to doctor visits implies that shared care hospital and GP consultaadditional nursing support via the nurse-led helpline. The method of safety-net monitoring (20% deteriorations were more appropriate (i.e. that treatment needed to be changed), but these results must be interpreted tion in disease designated as failure) meant that patients who deteriorated slowly (e.g. by 10% every 3 months) with caution as specific data on the content of outpatient visits was not recorded and a visit may have or patients who commenced the study with a VAS pain score already above 80% of the maximum did not trigger been appropriate without a change in medication. As clinical data were collected on a calendar basis (unrelated the review system. However, no patient deteriorated significantly over 2 yr. Furthermore, the failure rate was to clinic appointments), it is not possible to relate clinical status to any specific hospital visit. A further prospective similar in the two groups, indicating that these somewhat arbitrary cut-off points were compatible with the daystudy is under way to examine the appropriateness of both routine and requested visits.
to-day variation seen in patients under regular review and, indeed, may even have been too sensitive. The number of GP visits was increased in the shared
